Literature DB >> 25727650

Severe Angioedema Associated With Angiotensin-Converting Enzyme Inhibitor Therapy in Two Patients With Pollen-Food Allergy Syndrome.

Denisa Ferastraoaru1, David Rosenstreich1, Sunit Jariwala1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25727650      PMCID: PMC8031605          DOI: 10.1111/jch.12515

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  7 in total

1.  Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

Authors:  Baiju Malde; Jane Regalado; Paul A Greenberger
Journal:  Ann Allergy Asthma Immunol       Date:  2007-01       Impact factor: 6.347

Review 2.  Pollen food syndrome: update on the allergens.

Authors:  Alison Hofmann; A Wesley Burks
Journal:  Curr Allergy Asthma Rep       Date:  2008-09       Impact factor: 4.806

3.  Mechanisms of mediator release from human skin mast cells upon stimulation by the bradykinin analog, [DArg0-Hyp3-DPhe7]bradykinin.

Authors:  V L Cohan; D W MacGlashan; J A Warner; L M Lichtenstein; D Proud
Journal:  Biochem Pharmacol       Date:  1991-01-15       Impact factor: 5.858

4.  The oral allergy syndrome.

Authors:  C Ortolani; M Ispano; E Pastorello; A Bigi; R Ansaloni
Journal:  Ann Allergy       Date:  1988-12

5.  Angiotensin-converting enzyme inhibitors and angioedema.

Authors:  Mario Sánchez-Borges; Luis A González-Aveledo
Journal:  Allergy Asthma Immunol Res       Date:  2010-05-06       Impact factor: 5.764

6.  A survey on the management of pollen-food allergy syndrome in allergy practices.

Authors:  Songhui Ma; Scott H Sicherer; Anna Nowak-Wegrzyn
Journal:  J Allergy Clin Immunol       Date:  2003-10       Impact factor: 10.793

7.  Allergy to jackfruit: a novel example of Bet v 1-related food allergy.

Authors:  S T H P Bolhaar; R Ree; C A F M Bruijnzeel-Koomen; A C Knulst; L Zuidmeer
Journal:  Allergy       Date:  2004-11       Impact factor: 13.146

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.